Voice-Assisted Artificial Intelligence Enabled Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics: Primary results of the VOICE-COVID-19-II Randomized Trial.

ABSTRACT:

Background

Voice-assisted artificial intelligence (AI)-based systems may streamline clinical care among patients with heart failure (HF) and caregivers; however, randomized clinical trials are needed. We evaluated the potential for Amazon Alexa® (Alexa), a voice-assisted AI-based system, to conduct screening for SARS-CoV2 in a HF clinic.

Methods and results

We enrolled 52 participants (patients and caregivers) from a HF clinic, who were randomly assigned with a subsequent cross-over to receive a SARS-CoV-2 screening questionnaire via Alexa or healthcare personnel. Primary outcome was overall response concordance, as measured by the percentage of agreement and unweighted kappa scores between groups. A post-screening survey evaluated comfort with using the AI-based device. In

SUBMITTER: Sharma A 

PROVIDER: S-EPMC10201196 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature